Get the Stockscreener App
3.31
3.76%
0.12
Ardelyx Inc stock is traded at $3.31, with a volume of 2.35M.
It is up +3.76% in the last 24 hours and down -2.65% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$3.19
Open:
$3.24
24h Volume:
2.35M
Relative Volume:
0.48
Market Cap:
$854.60M
Revenue:
$427.68M
Net Income/Loss:
$-58.06M
P/E Ratio:
-13.90
EPS:
-0.2382
Net Cash Flow:
$-37.50M
1W Performance:
+1.22%
1M Performance:
-2.65%
6M Performance:
-47.46%
1Y Performance:
-35.48%
1-Day Range:
$3.19
$3.35
1-Week Range:
$3.06
$3.30
52-Week Range:
$3.06
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.31 | 854.60M | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
509.86 | 129.23B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.75 | 94.92B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
800.00 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
848.32 | 53.35B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
371.60 | 42.04B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-26 | Resumed | Ladenburg Thalmann | Buy |
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
New Strong Sell Stocks for October 9th - Zacks Investment Research
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026ARDX - Morningstar
SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026ARDX - TradingView
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - PR Newswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026 - FinancialContent
ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
New Strong Sell Stocks for October 7th - Zacks Investment Research
Ardelyx Inc (41X.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
ARDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardelyx (ARDX) - The National Law Review
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Baidu, Inc. (BIDU), Ardelyx, Inc. (ARDX), and Better Home & Finance Holding Company (BETR) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Securities Lawsuit Alert: Ardelyx, Inc. (ARDX) InvestorsContact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Ardelyx, Inc. (ARDX)Join by November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
Ardelyx to present hyperphosphatemia research at ASN meeting By Investing.com - Investing.com Nigeria
Ardelyx to present hyperphosphatemia research at ASN meeting By Investing.com - Investing.com South Africa
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
Ardelyx to present hyperphosphatemia research at ASN meeting - Investing.com
ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice – Contact Levi & Korsinsky - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Important Notice to Long-Term Shareholders of Anavex Life - GlobeNewswire
Many of about 550,000 U.S. dialysis patients have high blood phosphate. Ardelyx will present three studies. - Stock Titan
Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action - FinancialContent
Ardelyx Inc (41X.HM) Income Statement - Yahoo! Finance Canada
Ardelyx (NasdaqGM:ARDX) Stock Forecast & Analyst Predictions - Simply Wall Street
Ardelyx Inc (41X.HM) stock historical prices and data - Yahoo Finance UK
Ardelyx Inc. R (41X.HM) Q1 FY2026 earnings call transcript - Yahoo Finance
Ardelyx Inc. R (41X.HM) Q4 FY2025 earnings call transcript - Yahoo Finance
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
Is Ardelyx (ARDX) Undervalued Following Its PM360 Trailblazer Awards? - Simply Wall Street
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Ardelyx Inc (41X.HM) interactive stock chart - Yahoo Finance UK
Ardelyx Inc (41X.HM) income statement - Yahoo Finance UK
November 16, 2026 Deadline Approaching: Join Class Action Against Ardelyx, Inc. (ARDX)Contact Levi & Korsinsky - ACCESS Newswire
ARDX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (AR - The National Law Review
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 - TradingView
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 - PR Newswire
ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
A podcast on gut disorders wins gold at the PM360 awards - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in XTI Aerospace, Inc. of Class Action Lawsuit and Upcoming Deadlines – XTIA - GlobeNewswire Inc.
Debt to equity ratio of Ardelyx, Inc. – HAN:41X - TradingView
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ardelyx Inc Stock (ARDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Foster Eric Duane | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
11,900 |
47,957 |
0 |
| Bishop John E | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
25,500 |
102,765 |
0 |
| Brady James Parker | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
19,700 |
79,391 |
0 |
| Brady James Parker | Chief Human Resources Officer |
Aug 21 '26 |
Sale |
3.86 |
15,136 |
58,378 |
245,930 |
| Foster Eric Duane | Chief Commercial Officer |
Aug 21 '26 |
Sale |
3.86 |
8,562 |
33,023 |
409,410 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '26 |
Sale |
3.86 |
7,758 |
29,922 |
349,660 |
| Williams Laura A | Chief Patient Officer |
Aug 21 '26 |
Sale |
3.86 |
10,739 |
41,419 |
367,456 |
| RAAB MICHAEL | President & CEO |
Aug 21 '26 |
Sale |
3.86 |
58,574 |
225,914 |
1,619,792 |
| Hohenleitner Susan | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
2,650 |
10,680 |
0 |
| Reilly Joseph James | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
3,982 |
15,358 |
145,854 |
2.27%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):